...
首页> 外文期刊>Scientific reports. >Metabolomic characterization of myocardial ischemia-reperfusion injury in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention
【24h】

Metabolomic characterization of myocardial ischemia-reperfusion injury in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention

机译:心肌缺血再灌注损伤在经皮冠状动脉介入中的心肌缺血再灌注损伤代谢特征

获取原文
           

摘要

The aim of the study was to discover the metabolomic changes in plasma that occur during human Ischemia-Reperfusion (I/R) injury and to evaluate the diagnostic utility of plasma metabolomic biomarkers for determination of myocardial injury. Deciphering the details of plasma metabolome in ST-segment elevation myocardial infarction (STEMI) patients before and after primary percutaneous coronary interventions (PPCI) would allow for better understanding of the mechanisms involved during acute myocardial ischemia and reperfusion in humans. We performed a detailed non-targeted metabolomic analysis of plasma from 27 STEMI patients who had undergone PPCI in the first 48 hrs employing a LC-MS approach. Plasma metabolome at ischemic condition was compared to multiple time points after PPCI which allowed us to focus on changes in the reperfusion phase. Classification of the differential metabolites based on chemical taxonomy identified a major role for lipids and lipid-derived molecules. Biochemical pathway analysis identified valine, leucine and isoleucine biosynthesis, vitamin B6 metabolism and glutathione metabolism as the most significant metabolic pathways representing early response to I/R injury. We also identified phenyl alanine, tyrosine, linoleic acid and glycerophospholipid metabolism as the most significant pathways representing late response to I/R injury. A panel of three metabolites pentadecanoic acid, linoleoyl carnitine and 1-linoleoylglycerophosphocholine was discovered to have diagnostic value in determining the extent of I/R injury based on cardiac biomarkers. Using a non-targeted LC-MS approach, we have successfully generated the most comprehensive data to date on significant changes in the plasma metabolome in STEMI patients who had undergone PPCI in the first 48 hrs showing that lipid metabolites represent the largest cohort of molecules undergoing significant change.
机译:该研究的目的是发现人缺血再灌注(I / R)损伤期间发生的血浆的代谢组变化,并评估血浆代谢生物标志物测定心肌损伤的诊断效用。在初步经皮冠状动脉干预之前和之后的ST段抬高心肌梗死(STEMI)患者中血浆代谢物细节将允许更好地了解在急性心肌缺血和在人类再灌注过程中所涉及的机制。我们对从使用LC-MS方法的前48小时内经过PPCI的27名STASI患者进行了详细的非针对性代谢分析。缺血条件下的血浆代谢物与PPCI后的多个时间点进行比较,这使我们能够专注于再灌注阶段的变化。基于化学分类法的差分代谢物分类鉴定了脂质和脂质衍生的分子的主要作用。生物化学途径分析鉴定了缬氨酸,亮氨酸和异亮氨酸生物合成,维生素B6代谢和谷胱甘肽代谢作为最重要的代谢途径,代表I / R损伤的早期反应。我们还将苯丙氨酸,酪氨酸,亚油酸和甘油磷脂代谢作为最重要的途径鉴定为代表I / R损伤的后期反应的最显着途径。发现了三种代谢物戊二烷酸,亚油酰基肉碱和1-亚诺酰基甘油磷苷磷苷,在确定基于心脏生物标志物的I / R损伤程度方面具有诊断价值。使用非目标LC-MS方法,我们已成功地生成了最综合的数据,以迄今为止在第一个48小时内经过PPCI的STEMI患者中的血浆代谢物中的显着变化,显示脂质代谢物代表正在进行的最大分子队列的群体重大变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号